Caplan Jay David 4
4 · FRACTYL HEALTH, INC. · Filed Mar 3, 2025
Insider Transaction Report
Form 4
Caplan Jay David
President, Chief Product Off.
Transactions
- Award
Stock Option (right to buy)
2025-02-27+179,700→ 179,700 totalExercise: $1.46Exp: 2035-02-26→ Common Stock (179,700 underlying) - Award
Stock Option (right to buy)
2025-02-27+104,400→ 104,400 totalExercise: $15.00Exp: 2034-01-31→ Common Stock (104,400 underlying)
Footnotes (2)
- [F1]The stock option vests and becomes exercisable in equal installments on each of the first four anniversaries of the grant date, subject to the Reporting Persons's continuing in employment through each such vesting date.
- [F2]In connection with the Issuer's initial public offering, on February 1, 2024 the Reporting Person was granted, subject to the satisfaction of certain performance criteria, an option to purchase 174,000 shares of common stock to vest in the form of shares of the Issuer's common stock in four substantially equal installments on December 31, 2024 and each of the first three anniversaries thereof. On February 27, 2025, the Issuer's administrator determined that the performance criteria were partially met, resulting in 104,400 shares subject to such option being earned, of which 25% vested on December 31, 2024 and the remaining 75% will vest in substantially equal installments on the first three anniversaries thereof.